Aflatoxin-Guanine DNA Adducts and Oxidatively Induced DNA Damage in Aflatoxin-Treated Mice in Vivo As Measured by Liquid Chromatography-Tandem Mass Spectrometry with Isotope Dilution

Overview

Journal Chem Res Toxicol

Publisher American Chemical Society

Specialty Toxicology

Date 2018 Dec 12

PMID 30525498

Citations 16

Authors

Erdem Coskun

Pawel Jaruga

Vladimir Vartanian

Onur Erdem

Patricia A Egner

John D Groopman

R Stephen Lloyd

Miral Dizdaroglu

Affiliations

Soon will be listed here.

Abstract

Dietary exposure to aflatoxin B (AFB) is a significant contributor to the incidence of hepatocellular carcinomas globally. AFB exposure leads to the formation of AFB-N-guanine (AFB-N-Gua) and two diastereomers of the imidazole ring-opened 8,9-dihydro-8-(2,6-diamino-4-oxo-3,4-dihydropyrimid-5-yl-formamido)-9-hydroxyaflatoxin B (AFB-FapyGua) in DNA. These adducts lead to G → T transversion mutations with the ring-opened adduct being more mutagenic than the cationic species. Accurate measurement of these three adducts as biomarkers in DNA and urine will help identify dietary exposure to AFB as a risk factor in the development of hepatocellular carcinoma worldwide. Herein, we report an improved methodology for the measurement of AFB-N-Gua and the two diastereomers of AFB-FapyGua using liquid chromatography-tandem mass spectrometry with isotope dilution. We measured the levels of these compounds in liver DNA of six control mice and six AFB-treated mice. Levels varying from 1.5 to 45 lesions/10 DNA bases in AFB-treated mice were detected depending on the compound and animal. No background levels of these adducts were detected in control mice. We also tested whether the AFB treatment caused oxidatively induced DNA base damage using gas chromatography-tandem mass spectrometry with isotope dilution. Although background levels of several pyrimidine- and purine-derived lesions were detected, no increases in these levels were found upon AFB treatment of mice. On the other hand, significantly increased levels of (5' R)- and (5' S)-8,5'-cyclo-2'-deoxyadenosines were observed in liver DNA of AFB-treated mice. The impact of this work is expected to achieve the accurate measurement of three AFB-DNA adducts and oxidatively induced DNA lesions as biomarkers of AFB exposure as germane to investigations designed for the prevention of aflatoxin-related hepatocellular carcinomas and for determining the effects of genetic deficiencies in human populations.

Citing Articles

Aflatoxin B-induced DNA adduct formation in murine kidney and liver.

Jaruga P, Vartanian V, Minko I, Dizdaroglu M, Lloyd R Environ Toxicol Pharmacol. 2025; 114:104647.

PMID: 39884450 PMC: 11875873. DOI: 10.1016/j.etap.2025.104647.

The mycobiome in human cancer: analytical challenges, molecular mechanisms, and therapeutic implications.

Ding T, Liu C, Li Z Mol Cancer. 2025; 24(1):18.

PMID: 39815314 PMC: 11734361. DOI: 10.1186/s12943-025-02227-8.

Investigating the origins of the mutational signatures in cancer.

Boysen G, Alexandrov L, Rahbari R, Nookaew I, Ussery D, Chao M Nucleic Acids Res. 2025; 53(1).

PMID: 39778866 PMC: 11707540. DOI: 10.1093/nar/gkae1303.

The Distinct Roles of NEIL1 and XPA in Limiting Aflatoxin B1-Induced Mutagenesis in Mice.

Luzadder M, Minko I, Vartanian V, Davenport M, Fedorov L, McCullough A Mol Cancer Res. 2024; 23(1):46-58.

PMID: 39387543 PMC: 11695181. DOI: 10.1158/1541-7786.MCR-24-0577.

Functional characterization of single nucleotide polymorphic variants of DNA repair enzyme NEIL1 in South Asian populations.

Zuckerman J, Jackson A, Minko I, Kant M, Jaruga P, Stone M DNA Repair (Amst). 2024; 139:103695.

PMID: 38795603 PMC: 11218669. DOI: 10.1016/j.dnarep.2024.103695.

References

Lin Y, Li L, Makarova A, Burgers P, Stone M, Lloyd R . Error-prone replication bypass of the primary aflatoxin B1 DNA adduct, AFB1-N7-Gua. J Biol Chem. 2014; 289(26):18497-506. PMC: 4140297. DOI: 10.1074/jbc.M114.561563. View

Mulder J, Turner P, Massey T . Effect of 8-oxoguanine glycosylase deficiency on aflatoxin B1 tumourigenicity in mice. Mutagenesis. 2015; 30(3):401-9. PMC: 4422868. DOI: 10.1093/mutage/geu087. View

Birincioglu M, Jaruga P, Chowdhury G, Rodriguez H, Dizdaroglu M, Gates K . DNA base damage by the antitumor agent 3-amino-1,2,4-benzotriazine 1,4-dioxide (tirapazamine). J Am Chem Soc. 2003; 125(38):11607-15. DOI: 10.1021/ja0352146. View

Mulder J, Bondy G, Mehta R, Massey T . The impact of chronic Aflatoxin B1 exposure and p53 genotype on base excision repair in mouse lung and liver. Mutat Res. 2015; 773:63-8. DOI: 10.1016/j.mrfmmm.2015.01.015. View

Walton M, Egner P, Scholl P, Walker J, Kensler T, Groopman J . Liquid chromatography electrospray-mass spectrometry of urinary aflatoxin biomarkers: characterization and application to dosimetry and chemoprevention in rats. Chem Res Toxicol. 2001; 14(7):919-26. DOI: 10.1021/tx010063a. View

Jaruga P, Speina E, Gackowski D, Tudek B, Olinski R . Endogenous oxidative DNA base modifications analysed with repair enzymes and GC/MS technique. Nucleic Acids Res. 2000; 28(6):E16. PMC: 111057. DOI: 10.1093/nar/28.6.e16. View

Hsu I, Metcalf R, Sun T, Welsh J, Wang N, Harris C . Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature. 1991; 350(6317):427-8. DOI: 10.1038/350427a0. View

Pednekar V, Weerasooriya S, Jasti V, Basu A . Mutagenicity and genotoxicity of (5'S)-8,5'-cyclo-2'-deoxyadenosine in Escherichia coli and replication of (5'S)-8,5'-cyclopurine-2'-deoxynucleosides in vitro by DNA polymerase IV, exo-free Klenow fragment, and Dpo4. Chem Res Toxicol. 2014; 27(2):200-10. PMC: 3952113. DOI: 10.1021/tx4002786. View

Kuraoka I, Bender C, Romieu A, Cadet J, Wood R, Lindahl T . Removal of oxygen free-radical-induced 5',8-purine cyclodeoxynucleosides from DNA by the nucleotide excision-repair pathway in human cells. Proc Natl Acad Sci U S A. 2000; 97(8):3832-7. PMC: 18102. DOI: 10.1073/pnas.070471597. View

10.

Bos J, Fearon E, Hamilton S, Verlaan-de Vries M, VAN Boom J, Van Der Eb A . Prevalence of ras gene mutations in human colorectal cancers. Nature. 1987; 327(6120):293-7. DOI: 10.1038/327293a0. View

11.

Leadon S, Tyrrell R, Cerutti P . Excision repair of aflatoxin B1-DNA adducts in human fibroblasts. Cancer Res. 1981; 41(12 Pt 1):5125-9. View

12.

Brown K, Deng J, Iyer R, Iyer L, Voehler M, Stone M . Unraveling the aflatoxin-FAPY conundrum: structural basis for differential replicative processing of isomeric forms of the formamidopyrimidine-type DNA adduct of aflatoxin B1. J Am Chem Soc. 2006; 128(47):15188-99. PMC: 2693076. DOI: 10.1021/ja063781y. View

13.

Shen H, Ong C, Lee B, Shi C . Aflatoxin B1-induced 8-hydroxydeoxyguanosine formation in rat hepatic DNA. Carcinogenesis. 1995; 16(2):419-22. DOI: 10.1093/carcin/16.2.419. View

14.

Martin C, Garner R . Aflatoxin B -oxide generated by chemical or enzymic oxidation of aflatoxin B1 causes guanine substitution in nucleic acids. Nature. 1977; 267(5614):863-5. DOI: 10.1038/267863a0. View

15.

Blonski W, Kotlyar D, Forde K . Non-viral causes of hepatocellular carcinoma. World J Gastroenterol. 2010; 16(29):3603-15. PMC: 2915420. DOI: 10.3748/wjg.v16.i29.3603. View

16.

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

17.

Rodriguez H, Jurado J, Laval J, Dizdaroglu M . Comparison of the levels of 8-hydroxyguanine in DNA as measured by gas chromatography mass spectrometry following hydrolysis of DNA by Escherichia coli Fpg protein or formic acid. Nucleic Acids Res. 2000; 28(15):E75. PMC: 102694. DOI: 10.1093/nar/28.15.e75. View

18.

Jaruga P, Kirkali G, Dizdaroglu M . Measurement of formamidopyrimidines in DNA. Free Radic Biol Med. 2008; 45(12):1601-9. DOI: 10.1016/j.freeradbiomed.2008.09.019. View

19.

Croy R, Essigmann J, Reinhold V, Wogan G . Identification of the principal aflatoxin B1-DNA adduct formed in vivo in rat liver. Proc Natl Acad Sci U S A. 1978; 75(4):1745-9. PMC: 392416. DOI: 10.1073/pnas.75.4.1745. View

20.

Groopman J, Donahue P, Zhu J, Chen J, Wogan G . Aflatoxin metabolism in humans: detection of metabolites and nucleic acid adducts in urine by affinity chromatography. Proc Natl Acad Sci U S A. 1985; 82(19):6492-6. PMC: 390743. DOI: 10.1073/pnas.82.19.6492. View